 reperfus adjunct therapi benefici effect coronari thrombolyt therapi certain adjunct therapi proven valu benefit spite theoret advantag clinic trial acetylsalicyl mortal reduct thrombolyt therapi strong theoret rational use heparin evid benefit exist small angiograph trial clinic benefit earli intraven beta-block prethrombolysi era modest benefit extens data adjuv use thrombolysi avail trial intraven nitrat mortal prethrombolysi era trial thrombolyt therapi calcium channel blocker spite varieti theoret benefit valu subacut set diltiazem benefit subgroup patient non-o-wav infarct angiotensin-convert enzym inhibitor like valu survivor acut myocardi infarct left ventricular dysfunct benefit acut use experiment infarct clinic trial